Shipeng He
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 25
- Ubiquitin and proteasome pathways 14
- Histone Deacetylase Inhibitors Research 7
- RNA Interference and Gene Delivery 4
- Oncology 27
- Peptidase Inhibition and Analysis 17
- Co-authors
- Chunquan Sheng (36 shared papers)Guoqiang Dong (28 shared papers)Yu Ding (1 shared paper)Fei Gao (9 shared papers)Shanchao Wu (7 shared papers)Junhui Ma (3 shared papers)Wei Wang (6 shared papers)Junfei Cheng (6 shared papers)
- Journals
- Journal of Medicinal Chemistry (9 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Bioorganic Chemistry (4 papers)Angewandte Chemie International Edition (4 papers)Acta Pharmaceutica Sinica B (3 papers)
- Partner nations
- ChinaUnited StatesArmenia
In The Last Decade
Shipeng He
60 papers receiving 1.6k citations
Shipeng He's Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 222
- Oncology 533
- Molecular Biology 1.2k
- Biological Psychiatry 27
- Organic Chemistry 256
Countries citing papers authored by Shipeng He
This map shows the geographic impact of Shipeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipeng He more than expected).
Fields of papers citing papers by Shipeng He
This network shows the impact of papers produced by Shipeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipeng He. The network helps show where Shipeng He may publish in the future.
Co-authors
The 25 scholars most cited alongside Shipeng He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery Hit paper breakdown → | 2021 | 230 |
| 2 | Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer Hit paper breakdown → | 2021 | 221 |
| 3 | 2020 | 128 | |
| 4 | 2022 | 82 | |
| 5 | 2023 | 71 | |
| 6 | 2020 | 66 | |
| 7 | 2015 | 63 | |
| 8 | 2018 | 62 | |
| 9 | 2018 | 51 | |
| 10 | 2022 | 50 | |
| 11 | 2021 | 34 | |
| 12 | 2022 | 30 | |
| 13 | 2022 | 30 | |
| 14 | 2021 | 29 | |
| 15 | 2014 | 27 | |
| 16 | 2023 | 24 | |
| 17 | 2017 | 24 | |
| 18 | 2024 | 24 | |
| 19 | 2022 | 23 | |
| 20 | 2017 | 23 |
About Shipeng He
Shipeng He is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 65 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (25 papers), Peptidase Inhibition and Analysis (17 papers), Ubiquitin and proteasome pathways (14 papers), Histone Deacetylase Inhibitors Research (7 papers), Multiple Myeloma Research and Treatments (6 papers), Antimicrobial Peptides and Activities (5 papers), Nanoplatforms for cancer theranostics (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Hematology (222 citations), Oncology (533 citations), Molecular Biology (1.2k citations), Biological Psychiatry (27 citations) and Organic Chemistry (256 citations). Shipeng He has collaborated with scholars based in China, United States and Armenia. Frequent co-authors include Chunquan Sheng, Guoqiang Dong, Yu Ding, Fei Gao, Shanchao Wu, Junhui Ma, Wei Wang, Junfei Cheng, Ying Wu and Yu Li. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Bioorganic Chemistry, Angewandte Chemie International Edition and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.